These are powerful compounds, Gler said
A 2024 survey of 1,847 patients using compounded GLP-1 medications (Martinez et al., Journal of Managed Care Pharmacy) found that 19% experienced at least one concentration change across their first year of treatment
Safety, Pharmacokinetics, and Efficacy Of BP-100-1.01 (Liposomal Grb-2 Antisense Oligonucleotide) In Patients With Refractory Or Relapsed Acute Myeloid Leukemia (AML), Philadelphia Chromosome Positive Chronic Myelogenous Leukemia (CML), Acute Lymphoblastic Leukemia (ALL), and Myelodysplastic Syndrome (MDS)
IC 025 was calculated using the processed dataset to conduct the above sensitivity analyses
This research peptide is valued for its stability in lyophilized form, excellent solubility in sterile water, and high purity, making it suitable for controlled laboratory settings
Common side effects of drugs in this class include nausea, dizziness, and sleepiness